Literature DB >> 6174949

Interaction of the antitumour drug 4'-(9-acridinylamino)-methanesulfon-m-anisidine.HCl (m-AMSA) with nucleic acids.

F Hudecz, J Kajtár, M Szekerke.   

Abstract

The interaction of AMSA with nucleic acids was studied by several techniques. Melting temperature and CD studies equally suggest that AMSA-binding is interfering with the secondary structure of DNA. An overlap by two mechanism of binding seems to exist. Based on the CD measurements at low drug concentration intercalation is the most likely way of binding. At higher drug concentration stacking interaction predominates leading to cooperativity and formation of oriented sheets of aromatic ring-systems as reflected in the optical activity induced in the metachromatic band of the achiral drug. No base-pair specificity could be confirmed; however, a high affinity of AMSA to poly(A) chains was demonstrated. The CD measurements did not indicate any significant interaction with RNA. The selectivity of the AMSA-DNA interaction can be regarded as an important argument in favour of the role of this interaction in the anti-tumour effect of the drug.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6174949      PMCID: PMC327654          DOI: 10.1093/nar/9.24.6959

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  11 in total

1.  DNA-binding characteristics of acridinylmethanesulphonanilide drugs: comparison with antitumour properties.

Authors:  M J Waring
Journal:  Eur J Cancer       Date:  1976-12       Impact factor: 9.162

2.  Interaction of acridines and tetrahydroacridines with DNA at low DNA/dye ratios.

Authors:  A D Papaphilis; Y H Shaw
Journal:  Biochim Biophys Acta       Date:  1977-05-17

3.  Interaction of 9-peptidylaminoacridines with proteins and nucleic acids.

Authors:  G P Sachdev; A D Brownstein; J S Fruton
Journal:  J Biol Chem       Date:  1974-01-25       Impact factor: 5.157

4.  Interaction of antitumor drugs with human erythrocyte ghost membranes and mastocytoma P815: a spin label study.

Authors:  B K Sinha; C F Chignell
Journal:  Biochem Biophys Res Commun       Date:  1979-02-28       Impact factor: 3.575

5.  Potential antitumor agents. 14. Acridylmethanesulfonanilides.

Authors:  B F Cain; R N Seelye; G J Atwell
Journal:  J Med Chem       Date:  1974-09       Impact factor: 7.446

6.  On the complex formation of acridine dyes with DNA. VII. Dependence of the binding on the dye structure.

Authors:  G Löber; G Achtert
Journal:  Biopolymers       Date:  1969       Impact factor: 2.505

7.  Kinetic response of cultured Chinese hamster cells to treatment with 4'-[(9-acridinyl)-amino]methanesulphon-m-anisidide-HCl.

Authors:  R A Tobey; L L Deaven; M S Oka
Journal:  J Natl Cancer Inst       Date:  1978-05       Impact factor: 13.506

8.  Potential antitumor agents. 16.4'-(Acridin-9-ylamino)methanesulfonanilides.

Authors:  B F Cain; G J Atwell; W A Denny
Journal:  J Med Chem       Date:  1975-11       Impact factor: 7.446

9.  Cell-cycle-specific chromosome damage following treatment of cultured Chinese hamster cells with 4'-[(9-acridinyl)-amino]methanesulphon-m-anisidide-HCl.

Authors:  L L Deaven; M S Oka; R A Tobey
Journal:  J Natl Cancer Inst       Date:  1978-05       Impact factor: 13.506

10.  Interaction of 4'-(9-acridinylamino)methanesulfon-m-anisidide with DNA and inhibition of oncornavirus reverse transcriptase and cellular nucleic acid polymerases.

Authors:  P E Gormley; V S Sethi; R L Cysyk
Journal:  Cancer Res       Date:  1978-05       Impact factor: 12.701

View more
  1 in total

1.  Design of a new DNA-polyintercalating drug, a bisacridinyl peptidic analogue of Triostin A.

Authors:  N Helbecque; J L Bernier; J P Hénichart
Journal:  Biochem J       Date:  1985-02-01       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.